BMO upgrades Neurocrine to market perform on Ingrezza outlook (NBIX) mi-viri/iStock through Getty Photographs BMO Capital Markets has upgraded Neurocrine Biosciences (NASDAQ:NBIX) to market carry out, citing its … July 7,6:25 PM By Team News Nation Live In Markets